Steven Simonson - Mar 4, 2022 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Role: SVP, Chief Medical Officer
Signature: /s/ John P. Hamill, as Attorney-in-Fact
Stock symbol: WINT
Transactions as of: Mar 4, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/7/2022, 04:53 PM
Next filing: Mar 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WINT	Common Stock	Award	$0	+66.3K	+538.94%	$0.00	78.6K	Mar 4, 2022	Direct	F1
holding	WINT	Common Stock						292	Mar 4, 2022	By Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WINT	Employee Stock Option (Right to Buy)	Award	$0	+99.6K		$0.00	99.6K	Mar 4, 2022	Common Stock	99.6K	$1.02	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date.
F2	Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan.
F3	This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date.